Skip to main content

Month: December 2020

Auktioner over obligationer i serie 10F og 10G til refinansiering af FlexLån®

Selskabsmeddelelse nummer 96/2020Auktioner over obligationer i serie 10F og 10G til refinansiering af FlexLån®Realkredit Danmark gennemfører auktioner over SDRO til refinansiering af FlexLån® pr. 1. april 2021.Auktionerne vil blive afholdt fra og med mandag den 8. februar til og med fredag den 12. februar 2021. Da der kan ske ændringer af refinansieringsbeløbene og fordelingen på de enkelte årgange, fastlægges de specifikke auktionsdatoer per ISIN kode først i forbindelse med udmeldingen af de endelige mængder.De foreløbige udbudte mængder fremgår af bilag 1.De foreløbige mængder til refinansiering af FlexLån® i serie 10F og 10G vil blive opdateret ugentligt på rd.dk/investor fra og med uge 2.De endelige udbudte mængder og de enkelte ISIN koders specifikke auktionsdage offentliggøres i uge 5.DirektionenEventuel henvendelse kan rettes...

Continue reading

Platinex Extends Shear Zones With Discovery of New Zone on Shining Tree Property

TORONTO, Dec. 10, 2020 (GLOBE NEWSWIRE) — Platinex Inc. (CSE: PTX) (Frankfurt 9PX) (the “Company” or “Platinex“) is pleased to provide an update on the ongoing exploration program at Shining Tree Gold Project, Ontario which consists of a mechanical stripping and channel sample program in the Caswell area, geological mapping and sampling and a geochemical till sampling program in advance of IP surveys and a drilling program.In this work, Platinex has located a previously unknown shear zone north of the known extent of the Ribble Vein. This shear zone trends at 060° and two grab samples collected along it have returned 5.18 g Au/t and 3.69 g Au/t. Current interpretation of sheared quartz-carbonate alteration zones on the eastern portion of its Caswell project (see map) have them trending in an ENE direction...

Continue reading

Grieg Seafood ASA: Approval of prospectus

The Financial Supervisory Authority of Norway has on 9 December 2020 approved Supplement number 2 to the Base Prospectus dated 29 October 2020. The Supplement number 2 has been prepared in connection with the Additional Bonds (tap issue) of GSF01 G (ISIN NO0010885007) of NOK 500,000,000 as announced 27 November 2020.The Base Prospectus dated 29 October 2020, Supplement number 1 dated 23 October 2020, Supplement number 2 dated 9 December 2020 and Final Terms dated 9 December constitute a Prospectus, covering the listing of the Additional Bonds on Oslo Børs.The Prospectus and the Supplements are available at the company’s website: https://investor.griegseafood.com/share-&-bond#the-bondFor further information, please contact:Atle Harald Sandtorv, CFOatle.harald.sandtorv@griegseafood.com+47 908 45 252About Grieg Seafood ASA:Grieg Seafood...

Continue reading

Heimavellir hf.: Tilkynning vegna kröfuhafafunda skuldabréfaeigenda HEIMA071225, HEIMA071248 og HEIMA100646 sem átti að halda þann 11. desember 2020 – Afturköllun á fundarboði

Þann 3.desember sl. birtu Heimavellir fundarboð fyrir skuldabréfaeigendur skuldabréfaflokkanna HEIMA071225, HEIMA071248 og HEIMA100646. Til stóð að halda fundina þann 11. desember 2020 en nú hefur verið ákveðið að hætta við að halda fundina og fundarboðin því afturkölluð.Frekar upplýsingar veitir:Erlendur Kristjánsson, regluvörður Heimavallas:669-6940, Erlendur@Heimavellir.is

Continue reading

WRAP Selected Into United Kingdom Ministry of Defence Accelerator Program

TEMPE, Ariz., Dec. 10, 2020 (GLOBE NEWSWIRE) — WRAP Technologies, Inc. (the “Company” or “WRAP”) (Nasdaq: WRAP), an innovator of modern policing solutions, announced today that it bid and was selected by the United Kingdom Ministry of Defence into their Defence and Security Accelerator (DASA) for ‘Advancing Less Lethal Weapons.’The Defence and Security Accelerator (DASA) finds and funds exploitable innovation to support UK defence and security. DASA sought proposals for innovative technologies that allow law enforcement officers to safely prevent the escalation of conflict from long ranges during serious or violent circumstances. In the first phase of the program, WRAP’s engineering team will focus on developing proof of concept prototypes of longer-range remote restraint solutions.WRAP on Facebook: https://www.facebook.com/wraptechnologies/WRAP...

Continue reading

Kitov Announces Name Change to Purple Biotech Ltd.

New Name Reflects Company’s Evolution to Advancing First-in-Class Oncology TherapiesTEL AVIV, Israel, Dec. 10, 2020 (GLOBE NEWSWIRE) — Purple Biotech Ltd. (the “Company”) (NASDAQ/TASE: KTOV), a clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, today announced that it has changed its corporate name from Kitov Pharma Ltd. to Purple Biotech Ltd. The name change will be effective for trading purposes on the Tel Aviv Stock Exchange (TASE) and the NASDAQ Capital Market (NASDAQ) as of market open on December 22, 2020. At that time, the Company’s ordinary shares and American Depositary Shares (ADSs) will begin to trade under the new ticker symbol, “PPBT,” on the TASE and NASDAQ, respectively. The Company’s ordinary shares will continue to trade on the TASE and its ADSs will continue...

Continue reading

Golden Sky drills 1.34 g/t Au over 71.6 meters in discovery drill hole at Hotspot Property, Yukon Territory

VANCOUVER, British Columbia, Dec. 10, 2020 (GLOBE NEWSWIRE) — Golden Sky Minerals Corp. (AUEN.V) is pleased to announce results from the inaugural 2020 reverse circulation (RC) drill program at its 100%-owned Hotspot property in the Yukon Territory (see Table 1 for results and Table 2 for collar information).Six reverse circulation (RC) holes totalling 568.45m were drilled at the Sure Bet zone. All six holes returned significant near-surface gold (Au) bearing intervals.This first pass, shallow-hole drill campaign tested only a 200-metre strike length of the Sure Bet zone which is a 1.7-kilometre-long mineralized structure. An extensive follow-up diamond drill program has been recommended to test the zone at depth and along strike.The Hotspot property is a 46.4 km2 land package that contains numerous high priority drill targets that...

Continue reading

ADT Acquires Tech Startup CellBounce

CellBounce 3G-to-4G radio conversion solution certified for use on AT&T networkADT to deploy customer-installable conversion solution for 3G sunset expected to minimize the need for in-person, required upgradesBOCA RATON, Fla., Dec. 10, 2020 (GLOBE NEWSWIRE) — ADT (NYSE: ADT) has closed its previously announced acquisition of technology company CellBounce following thorough testing of its proprietary 3G-to-4G radio conversion technology, which is now certified for use on AT&T’s 4G cellular network. The user-installable device is expected to reduce the need for technicians to perform the required upgrade in many customer homes before the 3G network sunset. The device also will be made commercially available to third parties, allowing the larger security industry to benefit from this cost-saving radio conversion technology.“We...

Continue reading

Routemaster Completes the Acquisition of 49% of DeFi Holdings Inc.

TORONTO, Dec. 10, 2020 (GLOBE NEWSWIRE) — Routemaster Capital Inc. (the “Company” or “Routemaster”) (TSXV: RM) is pleased to announce that it has closed the transaction to acquire 49% of DeFi Holdings Inc. (“DeFi Holdings”), first announced on October 6, 2020 (the “Transaction”). Please see the Company`s press release dated October 6, 2020 and November 18, 2020 for additional information.Pursuant to the Transaction, Routemaster issued a total of 20,000,000 common shares of the Company to the shareholders of DeFi Holding in proportion to their pro rata shareholdings of DeFi Holding, in exchange for a 49% interest in DeFi Holdings. No finder fees were paid connection with, and no change of control of Routemaster resulted from, the Transaction.DeFi Holdings is a company focused on investing, incubating and managing trading technologies...

Continue reading

Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement, Creating a Combined $100M Revenue¹ Specialty Pharmaceutical Company

Merger accelerates transformation to profitability, with estimated annualized cost synergies of $15M beginning FY 2022 Aytu adds Neos’ established, multi-brand ADHD portfolio, enhancing Aytu’s footprint in pediatrics and expanding its presence in adjacent specialty care segmentsOpportunity to leverage and further enhance Neos RxConnect, a best-in-class patient support program, for Aytu’s product portfolio of best-in-class prescription therapeutics and consumer health productsCompanies to host joint conference call today at 8:30 am ETENGLEWOOD, Colo. and GRAND PRAIRIE, Texas, Dec. 10, 2020 (GLOBE NEWSWIRE) — Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, and Neos Therapeutics, Inc. (NASDAQ: NEOS), a commercial-stage pharmaceutical...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.